Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis

Kabore, Lassane; Ouattara, Seydou; Sawadogo, François; Gervaix, Alain; Galetto-Lacour, Annik; Karama, Robert; Traoré, Amado T; Méda, Bertrand; Tall, Haoua; Essoh, Alima T; Gessner, Bradford D; Moïsi, Jennifer C

doi:10.1016/j.ijid.2020.03.051

Scientific article

English

Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis

ContributorsKabore, Lassane

; Ouattara, Seydou; Sawadogo, François; Gervaix, Alain; Galetto-Lacour, Annik; Karama, Robert; Traoré, Amado T; Méda, Bertrand; Tall, Haoua; Essoh, Alima T; Gessner, Bradford D; Moïsi, Jennifer C

Published inInternational Journal of Infectious Diseases, vol. 96, p. 31-38

Publication date2020

Abstract

Pneumococcal disease is a major public health concern globally and particularly in Burkina Faso, where the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced nationwide into the routine immunization schedule in 2013. The aim of this study was to evaluate vaccine impact on all-cause pneumonia hospitalizations among children <5 years of age.

Keywords

Burkina Faso/epidemiology
Child
Preschool
Female
Hospitalization
Humans
Incidence
Infant
Infant
Newborn
Male
Pneumococcal Infections/epidemiology/prevention & control
Pneumococcal Vaccines
Retrospective Studies
Vaccination

Affiliation entities

Research groups

Etiologie des pneumonies et marqueurs inflammatoires chez l'enfant fébrile (183)

Citation (ISO format)

KABORE, Lassane et al. Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis. In: International Journal of Infectious Diseases, 2020, vol. 96, p. 31–38. doi: 10.1016/j.ijid.2020.03.051